Table S3 showed the hazard ratios of the impacts of tumor immune cells on lung cancer. The CD8+ T-cells, CD4+ naive T-cells, DC and CD4+ Tcm maintained the significance after adjustment for stage, grade, gender and histologic cell type (p = 0.004, 0.046, 0.04 and 0.035, respectively) (Table S3). After adjustment, the pro B-cells showed borderline significance (p = 0.058). The gene discussed is CD4; the disease is lung cancer.